Kevin Etzkorn

Mr. Etzkorn brings over ten years of venture capital experience and more than thirteen years of operational and technical management experience to the Fund. Prior to joining Heron, Mr. Etzkorn was a Principal at CID Capital, a life science and technology venture fund. W

hile at CID, his portfolio responsibilities included: Axiomed Spine Corporation, Bridge Semiconductor Corporation, EKOS Corporation, HyperNex, Inc. (acquired by Nova Measuring Instruments) and Renal Solutions, Inc. (acquired by Fresenius Medical Care).

Prior to joining CID Capital in 2001, Mr. Etzkorn spent thirteen years in the U.S. Navy in a variety of technical and supervisory roles, most recently as a Nuclear Engineer and Comm

unications Officer aboard the Fleet Ballistic Missile Submarine USS ALASKA, where he was responsible for the establishment and management of its Information Technology Department. He also served as an Assistant Professor in the Department of Naval Science at the University of Illinois. Mr. Etzkorn has served as an advisor to the National Science Foundation for the Small Business Innovation Research (SBIR) Program and

as an advisory board member for the Telemark Group, a New York based investment fund. He received his M.B.A. from the University of Illinois and a bachelor’s degree in Electrical and Computer Engineering from the University of Wisconsin.

Mr. Etzkorn led Heron’s investments in AirXpanders, Celleration and BioSET, Inc.  He also led the firm’s investment in Atlantis Components, Inc. which was sold to Astra Tech AB, a subsidiary of AstraZeneca, in 2007.